To gain insight into the role of LASS2 in chemoresistance in bladder cancer, paraffin-embedded specimens were analyzed by IHC in a cohort of MIBC patients who underwent cisplatin-based NAC (Additional file 1). Here, CERS2 is linked to urinary bladder carcinoma.